CTLA-4 primarily affects T cell priming by antigen-presenting cells in lymphatic organs, whereas PD-1/PD-L1 affects T cell exhaustion on the periphery, and the difference in action sites causes the difference in the incidence and severity of hepatitis [11]. This evidence concerns the gene PDCD1 and hepatitis A virus infection.